Taking people in FranceNo phase
Blood Test for Diagnosing Active and Latent Tuberculosis
Checks how well a blood test detects tuberculosis in adults.
Key facts
- Who runs it
- Assistance Publique Hopitaux De Marseille
- Where
- Marseille, FranceSee the site
- Trial code
- Registry title
- Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 30 Jul 2024
- Expected to end
- 1 Feb 2028
- Type of study
- Interventional
- Treatments tested
- test IGRA
- TEST QUATIFERON TB Gold Plus
- Record updated
- 1 August 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who come for care of tuberculosis disease and who have had or will have a prescribed reference IGRA test. It tests a new TB blood test.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- People presenting for treatment of tuberculosis disease
- Biomarker or test result
- Has had or will have a medically prescribed reference IGRA test for tuberculosis screening
Main reasons for not taking part
- People in an exclusion period from another study
- Pregnant, in labour or breast-feeding women
- People deprived of liberty by a court or administrative decision
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Individual at least 18 years of age
- Patient presenting for treatment of tuberculosis disease
- Having undergone or benefiting from screening for tuberculosis using a medically prescribed reference IGRA test
- Informed patient who has not expressed opposition to participating in the study; French-speaking patient with unambiguous understanding of oral and written instructions
Who cannot take part
- Persons in a period of exclusion from another study
- Pregnant, parturient or breast-feeding women
- Person deprived of liberty by judicial or administrative decision
Where in France
- Assistance Publique Hôpitaux de MarseilleMarseille, FranceContact: ALEXANDRA GIULIANITaking people
About the trial
What the trial wants to find out
Methodology This is a single-center study carried out as part of routine patient care.
Read full original descriptionShow less
The aim of the study is to determine the performance of the 2nd generation TB-IGRA test in the diagnosis of tuberculosis.
The group in the trial
- TUBERCULOSIS (LATENTE OR ACTIVE) ARMTreatment being tested
Treatment: test IGRA and TEST QUATIFERON TB Gold Plus
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
- Plain-language title
- Blood Test for Diagnosing Active and Latent TuberculosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 1 August 2024